These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 8925351)
1. A centralized system for monitoring clozapine use in British Columbia. Black LL; Greenidge LL; Ehmann T; Ganesan S; Honer WG Psychiatr Serv; 1996 Jan; 47(1):81-3. PubMed ID: 8925351 [TBL] [Abstract][Full Text] [Related]
2. Clozapine: the commitment to patient safety. Alphs LD; Anand R J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610 [TBL] [Abstract][Full Text] [Related]
4. Effects of the clozapine national registry system on incidence of deaths related to agranulocytosis. Honigfeld G Psychiatr Serv; 1996 Jan; 47(1):52-6. PubMed ID: 8925346 [TBL] [Abstract][Full Text] [Related]
16. Association between clozapine-induced agranulocytosis and HLA subtyping. Lopez-Garcia P; Teresa Rodriguez J; De Castro P; Landecho I; Zapata R J Clin Psychiatry; 2006 Oct; 67(10):1652-3. PubMed ID: 17107265 [No Abstract] [Full Text] [Related]
17. Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry. Honigfeld G; Arellano F; Sethi J; Bianchini A; Schein J J Clin Psychiatry; 1998; 59 Suppl 3():3-7. PubMed ID: 9541331 [TBL] [Abstract][Full Text] [Related]
18. Haematological side effects of clozapine: patient characteristics. Miller PR; Cutten AE N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414 [TBL] [Abstract][Full Text] [Related]
19. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Atkin K; Kendall F; Gould D; Freeman H; Liberman J; O'Sullivan D Br J Psychiatry; 1996 Oct; 169(4):483-8. PubMed ID: 8894200 [TBL] [Abstract][Full Text] [Related]
20. [Hematologic effects of clozapine: evaluation of the international experience]. Lamarque V Encephale; 1995 Jun; 21 Spec No 3():59-60. PubMed ID: 7628344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]